These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23166374)

  • 21. Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.
    Streicher EM; Sampson SL; Dheda K; Dolby T; Simpson JA; Victor TC; Gey van Pittius NC; van Helden PD; Warren RM
    J Clin Microbiol; 2015 Nov; 53(11):3650-3. PubMed ID: 26338863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
    Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
    PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.
    Ismail NA; Mvusi L; Nanoo A; Dreyer A; Omar SV; Babatunde S; Molebatsi T; van der Walt M; Adelekan A; Deyde V; Ihekweazu C; Madhi SA
    Lancet Infect Dis; 2018 Jul; 18(7):779-787. PubMed ID: 29685458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa.
    Nelson KN; Shah NS; Mathema B; Ismail N; Brust JCM; Brown TS; Auld SC; Omar SV; Morris N; Campbell A; Allana S; Moodley P; Mlisana K; Gandhi NR
    J Infect Dis; 2018 Nov; 218(12):1964-1973. PubMed ID: 29961879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six degrees of separation: use of social network analysis to better understand outbreaks of nosocomial transmission of extensively drug-resistant tuberculosis.
    Dharmadhikari AS
    J Infect Dis; 2013 Jan; 207(1):1-3. PubMed ID: 23166373
    [No Abstract]   [Full Text] [Related]  

  • 26. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.
    Calver AD; Falmer AA; Murray M; Strauss OJ; Streicher EM; Hanekom M; Liversage T; Masibi M; van Helden PD; Warren RM; Victor TC
    Emerg Infect Dis; 2010 Feb; 16(2):264-71. PubMed ID: 20113557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities.
    Auld SC; Shah NS; Mathema B; Brown TS; Ismail N; Omar SV; Brust JCM; Nelson KN; Allana S; Campbell A; Mlisana K; Moodley P; Gandhi NR
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30115614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.
    Basu S; Andrews JR; Poolman EM; Gandhi NR; Shah NS; Moll A; Moodley P; Galvani AP; Friedland GH
    Lancet; 2007 Oct; 370(9597):1500-7. PubMed ID: 17964351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
    Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G
    Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensively drug-resistant tuberculosis: epidemiology and management challenges.
    Dheda K; Warren RM; Zumla A; Grobusch MP
    Infect Dis Clin North Am; 2010 Sep; 24(3):705-25. PubMed ID: 20674800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms.
    Motiwala AS; Dai Y; Jones-López EC; Hwang SH; Lee JS; Cho SN; Via LE; Barry CE; Alland D
    J Infect Dis; 2010 Mar; 201(6):881-8. PubMed ID: 20136412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.
    Heysell SK; Thomas TA; Gandhi NR; Moll AP; Eksteen FJ; Coovadia Y; Roux L; Babaria P; Lalloo U; Friedland G; Shah S
    BMC Infect Dis; 2010 Dec; 10():344. PubMed ID: 21134279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
    Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL
    J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.